Applied genetic technologies corporation.

Applied Genetic Technologies Corporation October 23, 2022 at 7:05 PM · 10 min read Upfront consideration in cash of $0.34 per share representing a premium of approximately 42% over AGTC’s ...

Applied genetic technologies corporation. Things To Know About Applied genetic technologies corporation.

Applied Genetic Technologies (AGTC) advanced chart and technical analysis tool allows you to add studies and indicators such as Moving Averages (SMA and ...Applied Genetic Technologies Corporation T: (617) 843-5728 [email protected]. Stephen Potter Chief Business Officer Applied Genetic Technologies Corporation T: (617) 413-2754Jan 12, 2022 · Applied Genetic Technologies Corporation is a good speculative biotech to look into. It has had a rough past, but has still been pressing on with its gene therapies, especially AGTC-501. GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC ...Applied Genetic Technologies Corporation T: (617) 843-5728 [email protected]. Stephen Potter Chief Business Officer Applied Genetic Technologies Corporation T: (617) 413-2754

Applied Genetic Technologies is headquartered in Alachua, 14193 NW 119th Terrace, Suite #10, United States, and has 2 office locations.GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC ...Applied Genetic Technologies Corporation (NASDAQ:AGTC) is a Florida based clinical stage biotech concern. The company is focused on developing transformational genetic therapies for patients ...

The Company’s filings with the SEC are available to the public from the website maintained by the SEC at www.sec.gov. Additional copies of the tender offer materials may be obtained for free by contacting Applied Genetic Technologies Corporation at 14196 NW 119 th Terrace, Suite 10, Alachua, Florida, 32165, Attention: Chief Financial Officer.Oct 24, 2022 · GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 23, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical-stage biotechnology company focused on the...

Are you tired of the hassle that comes with filing your tax refund application through traditional means? Luckily, with advancements in technology, you can now apply for a tax refund online.Oct 26, 2022 · Applied Genetic Technologies Corporation (Nasdaq: AGTC) (“AGTC” or the “Company”) and a newly established portfolio company of Syncona Limited (“Syncona”), a leading healthcare company focused on founding, building and funding global leaders in life science, announced the commencement today of the previously announced tender offer ... GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of ...GAINESVILLE, Fla. and CAMBRIDGE, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical stage biotechnology company focused on the development ...Jun 13, 2023 · 1. According to the release, Syncona Limited partnered with additional investors including OSE to provide the new therapeutic venture with £96 million ($120 million) in funding. In November 2022, Syncona acquired Applied Genetic Technologies Corporation (AGTC). Beacon Therapeutics called AGTC-501, a gene therapy program currently in Phase II ...

Oct 24, 2022 · Applied Genetic Technologies Corporation Contacts: IR Contact: David Carey Lazar FINN Partners T: (212) 867-1768 [email protected]. Corporate Contact: Jonathan Lieber Chief Financial ...

Applied Genetic Technologies Corporation T: (617) 843-5728 [email protected]. Stephen Potter Chief Business Officer Applied Genetic Technologies Corporation T: (617) 413-2754

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of ...For decades, music lovers have been searching for the perfect home audio system that can deliver high-quality sound without taking up too much space. In 1984, Bose Corporation introduced a new product that would change the game forever – th...Syncona to Acquire Applied Genetic Technologies Corporation. Upfront consideration in cash of $0.34 per share representing a premium of approximately 42% over AGTC’s closing stock price on ...Applied Genetic Technologies Corporation (AGTC) and MeiraGTx lead the drive in ophthalmic gene therapies, with five and four assets in development, respectively.APPLIED GENETIC TECHNOLOGIES CORP : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in …22 oct. 2019 ... Applied Genetic Technologies Corporation (AGTC), a clinical-stage biotechnology company, developing transformational genetic therapies for ...

Apr 13, 2021 · Applied Genetic Technologies Corporation T: (617) 413-2754 [email protected] ... Dec 1, 2022 · GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today the successful ... Investors. AGTC is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system …Who uses fax machines anymore? Faxing is still relevant in today’s business environment, believe it or not. You may have a dusty fax machine in the basement with outdated technology. Advanced technology has helped faxing usage to increase, ...Syncona to Acquire Applied Genetic Technologies Corporation. Upfront consideration in cash of $0.34 per share representing a premium of approximately 42% over AGTC’s closing stock price on ...GAINESVILLE, Fla., and CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), a clinical-stage biotechnology ...A look at the shareholders of Applied Genetic Technologies Corporation (NASDAQ:AGTC) can tell us which group is most powerful. Institutions often own shares in more established companies, while it ...

Applied Genetic Technologies Corporation Contacts: IR Contact: David Carey Lazar FINN Partners T: (212) 867-1768 [email protected] Corporate Contact: Jonathan Lieber Chief Financial Officer Applied Genetic Technologies Corporation T: (617) 843-5778 [email protected]

GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 06, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical-stage biotechnology company focused on the ...Technology has led to tractors and other vehicles that allow fewer farmers to handle much larger fields. Pesticides prevent a significant amount of crop loss due to weeds and insects, and advanced genetic engineering has led to far better c...Applied Genetic Technologies Corporation Contacts: IR Contact: David Carey Lazar FINN Partners T: (212) 867-1768 [email protected]. Corporate Contact: Jonathan LieberWho uses fax machines anymore? Faxing is still relevant in today’s business environment, believe it or not. You may have a dusty fax machine in the basement with outdated technology. Advanced technology has helped faxing usage to increase, ...Beacon Therapeutics has kickstarted its entry into the gene therapy field with a $120m Series A financing. The British investment trust Syncona Limited launched the new ophthalmic gene therapy company by combining Applied Genetic Technologies Corporation’s (AGTC’s) late-stage X-linked retinitis pigmentosa (XLRP) programme with two ...Nov 28, 2023 · Applied Genetic Technologies Co. (NASDAQ:AGTC) released its quarterly earnings data on Tuesday, November, 9th. The biotechnology company reported ($0.40) EPS for the quarter, missing analysts' consensus estimates of ($0.35) by $0.05. During the same quarter last year, the firm posted ($0.60) earnings per share. Whether you want to file a complaint, ask a question or apply for a job, there are many reasons why you may need to reach a company’s corporate office. While the details for every company are somewhat different, you can try these steps to f...Applied Genetic Technologies Corporation T: (617) 843-5778 [email protected] ...

On January 11, 2022, Applied Genetic Technologies Corporation issued a press release announcing updated information regarding its ongoing X-linked retinitis pigmentosa (XLRP) clinical trials. A copy of this press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

Jun 12, 2023 · gchutka via Getty Images. Backed by millions of dollars of funding and a team of drug industry veterans, a new biotechnology company aims to create genetic medicines for eye diseases that lead to blindness. Beacon Therapeutics was founded earlier this year and has raised 96 million British pounds, or roughly $120 million, to support its mission.

Applied Genetic Technologies Corporation 2013 Employee Stock Purchase Plan (Full title of the plan(s)) Susan B. Washer . President and Chief Executive Officer . Applied Genetic Technologies Corporation . 11801 Research Drive, Suite D . Alachua, Florida 32615 (386) 462-2204GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today that a ...Applied Genetic Technologies Corporation (NASDAQ:AGTC) Q3 2021 Earnings Conference Call May 17, 2021 4:30 PM ETCompany Participants. Sue Washer – President and Chief Executive Officer. Stephen ...October 24, 2022. Venture firm Syncona is acquiring Applied Genetic Technologies Corporation, a company focused on the development and commercialization of adeno-associated virus-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases, for approximately $23.5 million plus ...Applied Genetic Technologies Corporation, a Cambridge- and Florida-based gene therapy firm better known as AGTC could go private through an acquisition by a Floridian investment firm.GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today the successful ...Oct 25, 2022 · The tender offer is approximately $23.5 million in cash ($0.34 per share). If completed, the acquisition – which has been termed a “low ball bid” by some – of AGTC will become Syncona’s ... GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today that a ...GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC ...It has been a tough year for gene therapy companies, and the latest player to accept reality is Applied Genetic Technologies Corporation, which today succumbed to a lowball bid from the investment company Syncona. It is clear to see why AGTC, running short of cash and with a flatlining share price, felt compelled to accept the offer.

On August 23, 2022, the Board of Directors of Applied Genetic Technologies Corporation (the “Company”) approved the bonus payment for the fiscal year ended June 30, 2022 and salary change for the fiscal year ending June 30, 2023 for the Company’s Chief Executive Officer, which are set forth in the following table.Investors. AGTC is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) diseases. AGTC is a leader in designing and constructing all critical gene therapy elements and bringing them together to develop customized therapies with the ...On August 23, 2022, the Board of Directors of Applied Genetic Technologies Corporation (the “Company”) approved the bonus payment for the fiscal year ended June 30, 2022 and salary change for the fiscal year ending June 30, 2023 for the Company’s Chief Executive Officer, which are set forth in the following table.Instagram:https://instagram. nasdaq adbe newsjepi vs divowho owns modello beerelli lily stock To wit, the Applied Genetic Technologies Corporation (NASDAQ:AGTC) share price managed to fall 68% over five long years. That is extremely sub-optimal, to say the least.Applied Genetic Technologies Corporation T: (617) 843-5728 [email protected]. Stephen Potter Chief Business Officer Applied Genetic Technologies Corporation T: (617) 413-2754 yeti newsamazon stocks prediction In today’s world, technology plays a role in everything we do, from banking and shopping to working and communicating with family and friends. First and foremost, guard your personal information with your life. Never give out your Social Se...GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of ... twitter stock purchase Alliance Acquisition Sub, Inc., a Delaware corporation (“Purchaser”), is offering to purchase (the “Offer”) all outstanding shares of common stock, par value $0.001 per share (the “Shares”), of Applied Genetic Technologies Corporation, a Delaware corporation (the “Company”), at a price per Share of $0.34, to the holder in cash, without interest and less any applicable ...Syncona Limited, a leading healthcare company focused on founding, building and funding global leaders in life science, today announces that its newly established portfolio company has agreed to acquire, by a tender offer, all outstanding shares of Applied Genetic Technologies Corporation ("AGTC") (Nasdaq: AGTC), a clinical-stage biotechnology ...Applied Genetic Technologies Corporation . 14193 NW 119 th Terrace, Suite 10 . Alachua, Florida 32615 (386) 462-2204 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications . on Behalf of the Person(s) Filing Statement) With copies to: